Week 11, 2021

  ECDC COVID-19 landing page    

Key figures on the vaccine rollout in the EU/EEA as of week 11, 2021 (21 March 2021)

Doses distributed and administered

Total number of vaccine doses distributed by manufacturers to EU/EEA countries: 71 297 602 (29 countries reporting)

Number of vaccine doses distributed by manufacturers to EU/EEA countries: median of 20.3 per hundred inhabitants (range: 9.9–31.8) (29 countries reporting)

Total number of vaccine doses administered: 59 718 011 (30 countries reporting)

Vaccine uptake in adults

Cumulative uptake of first vaccine dose among adults aged 18 years and above: median of 11.3% (range: 5.2–21.5%) (30 countries reporting)

Cumulative uptake of full vaccination among adults aged 18 years and above: median of 4.9% (range: 1.2–9.5%) (30 countries reporting)

Vaccine uptake in target groups

Cumulative uptake of the first vaccine dose among persons aged 80 years and above: median of 57.7% (range: 4.3–97.7%) (24 countries reporting)

Cumulative uptake of full vaccination among persons aged 80 years and above: median of 24.6% (range: <0.1%–68.8%) (24 countries reporting)

Cumulative uptake of the first vaccine dose among healthcare workers: median of 60.6% (range: 16.7–100%) (10 countries reporting)

Cumulative uptake of full vaccination among healthcare workers: median of 47% (range: 13–99.3%) (10 countries reporting)

For the list of countries reporting data for each indicator, see section 5

1 Introduction

1.1 Purpose and scope

This report provides an overview of the progress in the rollout of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA countries. It presents the number of vaccine doses distributed by manufacturers to each country for the different vaccines authorised for use in the EU and the number of first, second or unspecified doses administered to adult individuals overall, by age group and other selected target groups including healthcare workers (HCW) and residents in long-term care facilities (LTCF). Population denominators for total population and age-specific population are obtained from Eurostat.

The data presented in this report are collected through The European Surveillance System (TESSy). EU/EEA countries are requested to report basic indicators (number of vaccine doses distributed by manufacturers, number of first, second and unspecified doses administered) and data by target groups at national level twice a week (every Tuesday and Thursday). Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. Data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed.

While countries are asked to report data by detailed age groups, some may report in a simplified way (<60 and 60 years and above). Data are shown for each age group in this report. The estimated the vaccine uptake among healthcare workers and residents in long-term care facilities is presented for those countries reporting a denominator for these target groups. Data shown within tables and figures are cumulative except as indicated where time-series are shown.

This report complements the interactive ECDC COVID-19 Vaccine Tracker.

1.2 Navigation

Please use the floating table of contents and tabs to navigate between sections and sub-sections. Figures will expand when clicked upon and reduce to normal size when clicked upon again. The report should not be viewed in Internet Explorer as it may not display all features correctly.

1.3 Legal notice and disclaimer

A list of country-specific data disclaimers can be found in the ‘Country disclaimers’ section of the ECDC COVID-19 Vaccine Tracker.

ECDC’s legal notice and disclaimer can be found at https://www.ecdc.europa.eu/en/legal-notice

Users are advised to interpret all data with caution and be aware of their limitations.

These results from the initial phase of the rollout of national campaigns in the EU/EEA should be interpreted with great caution, and comparisons across countries are not advisable at this stage. For their correct interpretation, all possible factors affecting vaccine deployment in each country should be considered, as well as data completeness and quality. Data are subject to retrospective corrections.

Factors that should be taken into account when interpreting these data include the strategic approach of the first phase of the campaign, including priority groups and adaptation of vaccine policies (e.g. delivering the first dose to the highest possible number of individuals vs. ensuring availability of complete course of two doses), the vaccination start date, vaccination policies and dosing guidelines (e.g. on timing of second dose and use of a sixth dose from a five-dose vial), challenges in the logistics of deployment of the campaign and vaccine acceptance at the population level, among others.

Possible inconsistencies between the number of doses distributed to countries by the manufacturers and doses administered by vaccine products may be explained by one or more of the following: information on vaccine doses distributed and administered come from different sources at the national level with different reporting timeline; health providers obtain additional doses from each vial of certain vaccine products; data completeness.

2 Vaccine doses distributed and administered

2.1 Doses distributed by manufacturers to EU/EEA countries

2.1.1 Number of vaccine doses distributed by manufacturers to EU/EEA countries

Number of vaccine doses distributed by manufacturers to EU/EEA countries

This graph shows the total number of doses that have been distributed by manufacturers to each EU/EEA country as of 21 March 2021.

2.1.2 Vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

Vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

This graph shows the total number of doses that have been distributed by manufacturers to each EU/EEA country as of 21 March 2021 per hundred inhabitants aged 18 years and above.

2.1.3 Map of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

Map of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

The map shows the total number of doses that have been distributed by manufacturers to each EU/EEA country as of 21 March 2021 per hundred inhabitants aged 18 years and above.

2.2 Trends in vaccine dose distribution by manufacturers to EU/EEA countries

Cumulative weekly number of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

This graph shows the cumulative weekly number of vaccine doses distributed by manufacturers to EU/EEA countries as a rate per hundred inhabitants aged 18 years and above as of 21 March 2021.

2.3 Doses distributed by the manufacturers to EU/EEA countries by vaccine product

Vaccine doses distributed by the manufacturers to EU/EEA countries by product

This figure shows the proportion of vaccines distributed by manufacturers to EU/EEA countries by product as of 21 March 2021.

2.4 Doses administered in EU/EEA countries

2.4.1 Number of vaccine doses administered in EU/EEA countries

Number of vaccine doses administered in EU/EEA countries

This graph shows the total number of doses (first dose, second dose and unspecified dose) that have been administered in EU/EEA countries as of 21 March 2021.

2.4.2 Number of vaccine doses administered in EU/EEA countries per hundred inhabitants

Number of vaccine doses administered in EU/EEA countries per hundred inhabitants

This graph show the total number of doses (first dose, second dose and unspecified dose) that have been administered in EU/EEA countries as of 21 March 2021 per hundred inhabitants aged 18 years and above.

2.5 Doses administered out of total distributed to EU/EEA countries

Proportion of vaccine doses distributed to the EU/EEA countries that have been administered (%)

This graph shows the proportion of vaccine doses distributed to EU/EEA countries by the manufacturers that have been administered as of 21 March 2021. It reflects the utilisation of the available stock of vaccine doses in each country.

3 Uptake of the first vaccine dose among adults

3.1 Uptake of the first vaccine dose among adults by EU/EEA countries

3.1.1 Vaccine uptake for the first dose among adults aged 18 years and above (%) in EU/EEA countries

Vaccine uptake for the first dose among adults aged 18 years and above (%) in EU/EEA countries

This graph shows an estimate of the vaccine uptake for the first dose among adults aged 18 years and above in EU/EEA countries as of 21 March 2021. Vaccine uptake is expressed as a percentage and calculated as the total number of first doses administered divided by the total number of individuals aged 18 years and above in the country.

3.1.2 Map of national vaccine uptake for the first dose among adults aged 18 years and above (%) in EU/EEA countries

Map of national vaccine uptake for the first dose among adults aged 18 years and above (%) in EU/EEA countries

This map shows an estimate of the national vaccine uptake for the first dose among adults aged 18 years and above as of 21 March 2021 . Vaccine uptake is expressed as a percentage and calculated as the total number of first doses administered divided by the total number of individuals aged 18 years and above in the country.

3.2 Trends in uptake of the first vaccine dose among adults by EU/EEA countries

Cumulative weekly uptake of first doses among adults aged 18 years and above in EU/EEA countries

This graph shows the cumulative weekly uptake of first vaccine doses among adults aged 18 years and above in EU/EEA countries each week as a percentage over the country population (18 years or above) as of 21 March 2021.

3.3 Uptake of the first vaccine dose among adults by age group and EU/EEA countries

3.3.1 Uptake of the first dose among adults aged 18 years and above by detailed age group (%) in EU/EEA countries

Uptake of the first dose among adults aged 18 years and above by detailed age group (%) in EU/EEA countries

This graph shows the uptake of the first dose by age group as of 21 March 2021. This is calculated from the number of first doses administered by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) divided by the country population for the specific age group and displayed as a percentage.

3.3.2 Uptake of the first dose among adults aged 18 years and above by age group <60 and 60+ (%) in EU/EEA countries

Uptake of the first dose among adults aged 18 years and above by age group <60 and 60+ (%) in EU/EEA countries

This graph shows the uptake of the first dose by age group as of 21 March 2021. This is calculated from the number of first doses administered by age group (<60 and 60+) divided by the country population for the specific age group and displayed as a percentage.

3.3.3 Uptake of the first dose among adults aged 80+ (%) in EU/EEA countries

Uptake of the first dose among adults aged 80+ (%) in EU/EEA countries

This graph shows the uptake of the first dose in persons aged 80 years and above (80+) as of 21 March 2021. This is calculated from the number of first doses administered in persons 80+ divided by the country population for the specific age group and displayed as a percentage.

3.4 Number of first vaccine doses administered among adults by age group and EU/EEA countries

3.4.1 Number of first doses administered among adults aged 18 years and above by detailed age group in EU/EEA countries

Number of first doses administered among adults aged 18 years and above by detailed age group in EU/EEA countries

This graph shows the number of first doses administered by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) as of 21 March 2021.

3.4.2 Number of first doses administered among adults aged 18 years and above by age group <60 and 60+ in EU/EEA countries

Number of first doses administered among adults aged 18 years and above by age group <60 and 60+ in EU/EEA countries

This graph shows the number of first doses administered among adults aged 18 years and above by age group (<60 and 60+ years) as of 21 March 2021.

3.5 First vaccine dose in healthcare workers

3.5.1 Number of first doses administered to healthcare workers

Number of first doses administered to healthcare workers

This graph shows the number of first doses administered to healthcare workers (HCW) in EU/EEA countries as of 21 March 2021.

3.5.2 Uptake of the first vaccine dose among healthcare workers

Uptake of the first vaccine dose among healthcare workers

This graph shows the uptake of first doses among healthcare workers (HCW) in EU/EEA countries as of 21 March 2021.

3.6 First vaccine dose in long-term care facilities

3.6.1 Number of first doses administered to residents in long-term care facilities

Number of first doses administered to residents in long-term care facilities

This graph shows the number of first doses administered to residents in long-term care facilities (LTCF) in EU/EEA countries as of 21 March 2021.

3.6.2 Uptake of first doses among residents in long-term care facilities

Uptake of first doses among residents in long-term care facilities

This graph shows the uptake of first doses among residents in long-term care facilities (LTCF) in EU/EEA countries as of 21 March 2021.

4 Full vaccination uptake among adults

4.1 Full vaccination uptake among adults in EU/EEA countries

4.1.1 Full vaccination uptake among adults in EU/EEA countries

Full vaccination uptake among adults in EU/EEA countries

This graph shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries as a percentage over the country population aged 18 years and above as of 21 March 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.1.2 Map of full vaccination uptake among adults in EU/EEA countries

Map of full vaccination uptake among adults in EU/EEA countries

This map shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries as a percentage over the country population aged 18 years and above as of 21 March 2021 . Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.2 Trends in full vaccination uptake in EU/EEA countries among adults

Cumulative weekly uptake of full vaccination among adults in EU/EEA countries per hundred inhabitants

This graph shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries each week as a percentage over the country population aged 18 years and above as of 21 March 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.3 Full vaccination uptake by age group

4.3.1 Full vaccination uptake by age group (%) in EU/EEA countries

Full vaccination uptake by age group (%) in EU/EEA countries

This graph shows the uptake of full vaccination by age group as of 21 March 2021. This is calculated from the number of full vaccinations among adults by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) in EU/EEA countries divided by the country population for the specific age group and displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.3.2 Full vaccination uptake by age group <60 and 60+ (%) in EU/EEA countries

Full vaccination uptake by age group <60 and 60+ (%) in EU/EEA countries

This graph shows the uptake of full vaccination by age group as of 21 March 2021. This is calculated from the number of full vaccinations among adults by age group (<60 and 60+) in EU/EEA countries divided by the country population for the specific age group and displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.3.3 Full vaccination uptake among adults aged 80+ (%) in EU/EEA countries

Full vaccination uptake among adults aged 80+ (%) in EU/EEA countries

This graph shows the uptake of full vaccination by age group as of 21 March 2021. This is calculated from the number of full vaccinations among adults by age group (80+) in EU/EEA countries divided by the country population for the specific age group and displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.4 Number of full vaccinations among adults by age group

4.4.1 Number of full vaccinations among adults by age group in EU/EEA countries

Number of full vaccinations among adults by age group in EU/EEA countries

This graph shows the number of full vaccinations among adults by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) in EU/EEA countries as of 21 March 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.4.2 Number of full vaccinations among adults by age group <60 and 60+ in EU/EEA countries

Number of full vaccinations among adults by age group <60 and 60+ in EU/EEA countries

This graph shows the number full vaccinations among adults by age group (<60 and 60+ years) in EU/EEA countries as of 21 March 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.5 Full vaccination in healthcare workers

4.5.1 Number of full vaccinations in healthcare workers.

Number of full vaccinations in healthcare workers.

This graph shows the number of full vaccinations among HCW in EU/EEA countries as of 21 March 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.5.2 Uptake of full vaccination among healthcare workers.

Uptake of full vaccination among healthcare workers.

This graph shows the uptake of full vaccination among HCW in EU/EEA countries as of 21 March 2021 displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.6 Full vaccination in long-term care facilities

4.6.1 Number of full vaccinations in residents in long-term care facilities.

Number of full vaccinations in residents in long-term care facilities.

This graph shows the number of full vaccinations among residents of LTCF in EU/EEA countries as of 21 March 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.6.2 Uptake of full vaccination among residents in long-term care facilities.

Uptake of full vaccination among residents in long-term care facilities.

This graph shows the uptake of full vaccination among residents of LTCF in EU/EEA countries as of 21 March 2021displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

5 Data completeness

5.1 EU/EEA countries reporting COVID-19 vaccination data by week

Data as of as of 21 March 2021.

5.2 Reporting completeness for COVID-19 vaccination data by target group (age, healthcare workers and residents in long-term care facilities) and week.

Data as of as of 21 March 2021.

6 Reported data

The table below shows data reported at national level. The variables include: total doses received, number of first doses administered, number of second doses administered and number of administered doses classified as ‘unspecified’.

7 National References

7.1 National COVID-19 vaccine deployment plans

7.2 National data on vaccine rollout

&nbsp

8 Notes on the data

8.1 Specific data quality issues

Austria: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Belgium: Denominators for healthcare workers and residents in long-term care facilities not currently available. First vaccine doses administered to healthcare workers available up to week 9. Doses distributed to Belgium in week 11 not currently available.

Bulgaria: Vaccine doses administered disaggregated by vaccine product not available for the current week.

Croatia: Denominator for residents in long-term care facilities not currently available.

Cyprus: Vaccine doses administered are reported for persons aged 80 years and above until week 6; for persons 60 years and above thereafter. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Denmark: The number of doses administered may be greater than the total number of doses distributed to the country since healthcare workers obtain more doses than the expected number from each vial. Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Estonia: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Finland: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Germany: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Greece: Information on vaccine doses administered to residents in long-term care facilities not currently available.

Hungary: Vaccine uptake among healthcare workers may exceed 100% since, on an emergency basis, a continuously increasing number of individuals are being enrolled into the healthcare workforce to tackle the COVID-19 epidemic (e.g. medical students), whereas the denominator data reflects the official number of healthcare workers in the country.

Iceland: The number of doses administered may be greater than the number of doses distributed to the country due to usage of more doses per vial when possible. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Ireland: The number of doses administered may be greater than the  number of doses distributed to the country due to possible difference in the timing of availability of information on supplies delivered for the current week. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Italy: The number of doses administered may be greater than the  number of doses distributed to the country due to possible difference in the timing of availability of information on supplies delivered. Vaccine doses distributed to the country in week 10 and week 11 not currently reported. The rate of vaccine doses distributed per one hundred inhabitants may be underestimated. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Latvia: Denominators for healthcare workers and residents in long-term care facilities not currently available.

Liechtenstein: Some cumulative data have been reported in week 6 and week 9 to week 11. No trend analysis can be performed at the moment. Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Lithuania: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Malta: Denominators for healthcare workers and residents in long-term care facilities not currently available.

Netherlands: Denominators for healthcare workers and residents in long-term care facilities not currently available.

Norway: Data on vaccine doses not available by vaccine product. Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Poland: Denominators for healthcare workers and information on doses administered to residents in long-term care facilities not currently available.

Portugal: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities is not currently available. Vaccines administered in the region of Azores are reported cumulatively in week 10 and weekly after that.

Romania: Vaccinations distributed by manufacturers to the country and doses administered until week 4, 2021 are reported cumulatively in week 4. Denominators for residents in long-term care facilities not currently available.

Slovakia: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Slovenia: Information on vaccine doses administered to residents in long-term care facilities not currently available.

Sweden: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.